GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » EV-to-EBITDA

Bioqual (Bioqual) EV-to-EBITDA : 0.00 (As of Jun. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Bioqual EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bioqual's enterprise value is $0.00 Mil. Bioqual's EBITDA for the trailing twelve months (TTM) ended in May. 2018 was $6.08 Mil. Therefore, Bioqual's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Bioqual's EV-to-EBITDA or its related term are showing as below:

BIOQ's EV-to-EBITDA is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 16.11
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-01), Bioqual's stock price is $72.50. Bioqual's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2018 was $4.100. Therefore, Bioqual's PE Ratio for today is 17.68.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bioqual EV-to-EBITDA Historical Data

The historical data trend for Bioqual's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual EV-to-EBITDA Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.45 3.05 3.14 3.32 3.28

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.45 3.05 3.14 3.32 3.28

Competitive Comparison of Bioqual's EV-to-EBITDA

For the Diagnostics & Research subindustry, Bioqual's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bioqual's EV-to-EBITDA falls into.



Bioqual EV-to-EBITDA Calculation

Bioqual's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/6.077
=0.00

Bioqual's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioqual's EBITDA for the trailing twelve months (TTM) ended in May. 2018 was $6.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual  (OTCPK:BIOQ) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bioqual's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=72.50/4.100
=17.68

Bioqual's share price for today is $72.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioqual's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2018 was $4.100.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bioqual EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bioqual's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines